BRPI0910403A8 - Uso de um agente traçador de mpi, e, método para o monitoramento visual de um produto biocompatível. - Google Patents

Uso de um agente traçador de mpi, e, método para o monitoramento visual de um produto biocompatível.

Info

Publication number
BRPI0910403A8
BRPI0910403A8 BRPI0910403A BRPI0910403A BRPI0910403A8 BR PI0910403 A8 BRPI0910403 A8 BR PI0910403A8 BR PI0910403 A BRPI0910403 A BR PI0910403A BR PI0910403 A BRPI0910403 A BR PI0910403A BR PI0910403 A8 BRPI0910403 A8 BR PI0910403A8
Authority
BR
Brazil
Prior art keywords
biocompatible
mpi
visual monitoring
products
tracking agent
Prior art date
Application number
BRPI0910403A
Other languages
English (en)
Inventor
Markov Denis
M B Boeve Hans
Original Assignee
Koninklijke Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Philips Nv filed Critical Koninklijke Philips Nv
Publication of BRPI0910403A2 publication Critical patent/BRPI0910403A2/pt
Publication of BRPI0910403A8 publication Critical patent/BRPI0910403A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

USO DE UM AGENTE TRAÇADOR DE MPI, E, MÉTODO PARA O MONITORAMENTO VISUAL DE UM PRODUTO BIOCOMPATÍVEL. A presente invenção refere-se aos materiais e métodos para a formação de imagem não invasiva de produtos biocompatíveis. Os produtos biocompatíveis são fornecidos os quais podem ser visualizadas in vivo e in vitro, utilizando métodos de formação de imagem com partículas magnéticas. Observou-se que estes materiais podem ser empregados para o monitoramento do desenvolvimento, remodelação ou degradação de produtos biocompatíveis. Em outro aspecto, os produtos da invenção permitem o rastreamento de liberação da substância e podem ser usados para visualizar a liberação direcionada de agentes ativos.
BRPI0910403A 2008-04-03 2009-03-26 Uso de um agente traçador de mpi, e, método para o monitoramento visual de um produto biocompatível. BRPI0910403A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08103358 2008-04-03
PCT/IB2009/051274 WO2009122330A2 (en) 2008-04-03 2009-03-26 Biocompatible products for magnetic particle imaging

Publications (2)

Publication Number Publication Date
BRPI0910403A2 BRPI0910403A2 (pt) 2015-08-11
BRPI0910403A8 true BRPI0910403A8 (pt) 2015-11-10

Family

ID=40636921

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0910403A BRPI0910403A8 (pt) 2008-04-03 2009-03-26 Uso de um agente traçador de mpi, e, método para o monitoramento visual de um produto biocompatível.

Country Status (7)

Country Link
US (1) US20110027189A1 (pt)
EP (1) EP2274024B1 (pt)
JP (1) JP2011516462A (pt)
CN (1) CN101980730B (pt)
BR (1) BRPI0910403A8 (pt)
RU (1) RU2496525C2 (pt)
WO (1) WO2009122330A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5947790B2 (ja) * 2010-05-25 2016-07-06 クック・バイオテック・インコーポレイテッドＣｏｏｋ Ｂｉｏｔｅｃｈ Ｉｎｃｏｒｐｏｒａｔｅｄ 医療用移植片の細胞播種に有用な方法、基質、およびシステム
US8798716B1 (en) * 2011-11-03 2014-08-05 Solstice Corporation Fiducial markers and related methods
WO2014127772A1 (de) * 2013-02-20 2014-08-28 Topass Gmbh Orales kontrastmittel für die diagnostik des gastrointestinaltraktes mittels mpi
TWI459966B (zh) * 2013-03-06 2014-11-11 Univ Nat Chiao Tung 奈米粒子藥物載體、藥物組合物及其製造方法
WO2015095380A1 (en) * 2013-12-17 2015-06-25 Kassab Ghassan S Devices, systems and methods for tissue engineering of luminal grafts
CZ2014451A3 (cs) * 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
WO2017152127A1 (en) * 2016-03-03 2017-09-08 Amrita Vishwa Vidyapeetham Mri and ct contrast-enabled composite implants for image-guided tissue regeneration and therapy
CN109125924A (zh) * 2018-08-14 2019-01-04 上海白衣缘生物工程有限公司 一种生物套在电子器械心脏植入方面的应用
CN111870706B (zh) * 2020-08-24 2021-12-14 中国科学院长春应用化学研究所 一种可mri示踪显影的细胞微载体及制备方法
WO2023146474A2 (en) * 2022-01-27 2023-08-03 Agency For Science, Technology And Research A method of imaging an inanimate structural implant in a tissue
CN118416297A (zh) * 2023-05-11 2024-08-02 刘佳东 一种聚左旋乳酸粉剂及其制备方法和使用方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98744A0 (en) * 1990-07-06 1992-07-15 Gen Hospital Corp Method of studying biological tissue using monocrystalline particles
DE19921088C2 (de) * 1999-04-30 2003-08-07 Magforce Applic Gmbh Stent zur Offenhaltung gangartiger Strukturen
US7169618B2 (en) * 2000-06-28 2007-01-30 Skold Technology Magnetic particles and methods of producing coated magnetic particles
DE10151778A1 (de) * 2001-10-19 2003-05-08 Philips Corp Intellectual Pty Verfahren zur Ermittlung der räumlichen Verteilung magnetischer Partikel
US6962685B2 (en) * 2002-04-17 2005-11-08 International Business Machines Corporation Synthesis of magnetite nanoparticles and the process of forming Fe-based nanomaterials
US7101394B2 (en) * 2002-05-02 2006-09-05 Boston Scientific Scimed, Inc. Energetically-controlled delivery of biologically active material from an implanted medical device
DE10238853A1 (de) 2002-08-24 2004-03-04 Philips Intellectual Property & Standards Gmbh Verfahren zur lokalen Erwärmung mit magnetischen Partikeln
EP1615556B1 (en) 2003-04-15 2012-06-13 Philips Intellectual Property & Standards GmbH Method of determining state variables and changes in state variables
CN100581458C (zh) * 2003-04-15 2010-01-20 皇家飞利浦电子股份有限公司 物理、化学和/或生物学特性或状态变量的空间分辨测定方法
US20060025713A1 (en) * 2003-05-12 2006-02-02 Alex Rosengart Magnetic particle-based therapy
WO2005046733A1 (en) * 2003-11-17 2005-05-26 Philips Intellectual Property & Standards Gmbh Contrast agent for medical imaging techniques and usage thereof
US20060141149A1 (en) * 2004-12-29 2006-06-29 Industrial Technology Research Institute Method for forming superparamagnetic nanoparticles
US20060204445A1 (en) * 2005-03-11 2006-09-14 Anthony Atala Cell scaffold matrices with image contrast agents
EP1738773A1 (de) * 2005-06-29 2007-01-03 Schering AG Magnetische Eisenoxidpartikel enthaltende Zusammensetzung und deren Vervendung in bildgebenden Verfahren
EP1738774A1 (de) * 2005-06-29 2007-01-03 Schering AG Magnetische Eisenoxidpartikel enthaltende Zusammensetzungen und deren Verwendung in bildgebenden Verfahren

Also Published As

Publication number Publication date
EP2274024A2 (en) 2011-01-19
WO2009122330A2 (en) 2009-10-08
EP2274024B1 (en) 2013-05-15
WO2009122330A3 (en) 2010-07-29
CN101980730A (zh) 2011-02-23
RU2496525C2 (ru) 2013-10-27
BRPI0910403A2 (pt) 2015-08-11
RU2010144967A (ru) 2012-05-10
US20110027189A1 (en) 2011-02-03
CN101980730B (zh) 2015-02-25
JP2011516462A (ja) 2011-05-26

Similar Documents

Publication Publication Date Title
WO2009122330A3 (en) Biocompatible products for magnetic particle imaging
Jobke et al. Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients
ES2544967T3 (es) Formulación y método para la prevención y el tratamiento de las metástasis óseas o de otras enfermedades óseas
WO2009114776A3 (en) Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
CY1120888T1 (el) Διαδερμικες φαρμακευτικες συνθεσεις περιλαμβανοντας ενεργους παραγοντες
BRPI1012602A8 (pt) Linha que possui estruturas revestidas para ancoragem para ancoragem em tecidos biológicos e sistema para fechamento de ferida e kit de peças cirúrgicas
BR112013002601A2 (pt) corticosteróides para o tratamento de dor em articulação
MY148461A (en) Heteroaryl amide analogues as p2x7 antagonists
AR075423A1 (es) Composicion farmaceutica que comprende un inhibidor de sglt-2, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y sus usos
PH12015500407A1 (en) Methods of treating hypertriglyceridemia
BR112012015710A2 (pt) filtro para um artigo de fumar, artigo de fumar, utilização de um instrumento e método para aumentar a desintegração e/ou degradação de um artigo de fumar
MX2018011832A (es) Metodos y composiciones para uso en diagnostico de pacientes con cancer.
EP4219760A3 (en) Methods, compositions, and devices utilizing microrna to determine physiological conditions
BR112012010995A2 (pt) revestimentos e métodos de revestimento de agulhas cirúrgicas
BR112013000433A2 (pt) diagnóstico e tratamento de câncer de mama
HK1202415A1 (en) Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of use thereof
BR112013000776A2 (pt) método e formulação para tratamento de deficiência de ácido siálico
MX2011013726A (es) Nanodispersión de un medicamento y proceso para su preparación.
BR112015010395A2 (pt) composição para tratamento da pele com enxágue
WO2014153160A3 (en) METHOD OF ENHANCING THE BIODISTRIBUTION AND TISSUE TARGETING PROPERTIES OF THERAPEUTIC CeO2 PARTICLES VIA NANO-ENCAPSULATION AND COATING
CY1115725T1 (el) Ενωσεις, συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη των βητα-αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων
WO2012138913A3 (en) In vivo immunomagnetic hyperthermia platform for any cell or virus having a target surface receptor
BR112012011000A2 (pt) revestimentos e métodos de revestimento de agulhas cirúrgicas
MX2015017774A (es) Composiciones y metodos para el uso en el diagnostico medico.
MX2013006644A (es) Formulacion farmaceutica novedosa que comprende nsaid y ciclodextrina.

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: KONINKLIJKE PHILIPS N.V. (NL)

B25G Requested change of headquarter approved

Owner name: KONINKLIJKE PHILIPS N.V. (NL)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]